Humacyte (HUMA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.43, -2.50% vs the prior close of $0.44.
- Volume 5.94M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
HUMA dips 2.5% to $0.43. Closed at $0.43, -2.50% vs the prior close of $0.44. Day range $0.42–$0.46, opened at $0.45.
HUMA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — HUMA dips 2.5% to $0.43
- Closed at $0.43, -2.50% vs the prior close of $0.44. Day range $0.42–$0.46, opened at $0.45.
- Volume was 5.94M shares, 0.8x its 50-day average of 7.33M.
- Price is -24.6% vs its 50-day average ($0.57) and -49.0% vs its 200-day average ($0.84).
- 52-week range $0.34–$1.89; today's close sits at 6% of that range, 77.4% below the 52-week high.
Oct 15, 2026 — HUMA jumps 24.3% to $0.44 on 3.0x normal volume
- Closed at $0.44, +24.29% vs the prior close of $0.35. Day range $0.35–$0.45, opened at $0.37.
- Volume was 20.75M shares, 3.0x its 50-day average of 6.95M — unusually heavy trading.
- Price is -23.5% vs its 50-day average ($0.57) and -47.8% vs its 200-day average ($0.84).
- 52-week range $0.34–$1.89; today's close sits at 7% of that range, 76.8% below the 52-week high.
Oct 14, 2026 — HUMA dips 1.4% to $0.35, a 52-week low, 8 down days in a row
- Closed at $0.35, -1.39% vs the prior close of $0.36. Day range $0.34–$0.38, opened at $0.36.
- Volume was 5.43M shares, 0.8x its 50-day average of 6.90M.
- Price is -39.0% vs its 50-day average ($0.58) and -58.2% vs its 200-day average ($0.85).
- 52-week range $0.34–$1.89; today's close sits at 1% of that range, 81.3% below the 52-week high.
- That makes 8 straight losses.
Oct 13, 2026 — HUMA slides 7.9% to $0.36, a 52-week low on 1.8x normal volume
- Closed at $0.36, -7.95% vs the prior close of $0.39. Day range $0.36–$0.39, opened at $0.39.
- Volume was 12.35M shares, 1.8x its 50-day average of 6.72M — unusually heavy trading.
- Price is -38.9% vs its 50-day average ($0.59) and -57.8% vs its 200-day average ($0.85).
- 52-week range $0.36–$1.89; today's close sits at 0% of that range, 81.1% below the 52-week high.
- That makes 7 straight losses.
Oct 12, 2026 — HUMA slides 3.7% to $0.39, a 52-week low on 2.5x normal volume
- Closed at $0.39, -3.70% vs the prior close of $0.41. Day range $0.39–$0.41, opened at $0.40.
- Volume was 16.35M shares, 2.5x its 50-day average of 6.43M — unusually heavy trading.
- Price is -34.4% vs its 50-day average ($0.59) and -54.3% vs its 200-day average ($0.85).
- 52-week range $0.39–$1.89; today's close sits at 0% of that range, 79.4% below the 52-week high.
- That makes 6 straight losses.
Oct 9, 2026 — HUMA slides 9.4% to $0.41, a 52-week low, 5 down days in a row
- Closed at $0.41, -9.40% vs the prior close of $0.45. Day range $0.39–$0.45, opened at $0.44.
- Volume was 8.60M shares, 1.4x its 50-day average of 6.34M.
- Price is -32.5% vs its 50-day average ($0.60) and -52.7% vs its 200-day average ($0.86).
- 52-week range $0.39–$1.89; today's close sits at 1% of that range, 78.6% below the 52-week high.
- That makes 5 straight losses.
Oct 8, 2026 — HUMA slides 5.3% to $0.45, a 52-week low, 4 down days in a row
- Closed at $0.45, -5.30% vs the prior close of $0.47. Day range $0.44–$0.48, opened at $0.47.
- Volume was 5.49M shares, 0.9x its 50-day average of 6.31M.
- Price is -26.1% vs its 50-day average ($0.61) and -48.0% vs its 200-day average ($0.86).
- 52-week range $0.44–$1.89; today's close sits at 1% of that range, 76.4% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — HUMA dips 1.3% to $0.47, a 52-week low, 3 down days in a row
- Closed at $0.47, -1.26% vs the prior close of $0.48. Day range $0.46–$0.48, opened at $0.48.
- Volume was 3.91M shares, 0.6x its 50-day average of 6.27M.
- Price is -22.5% vs its 50-day average ($0.61) and -45.4% vs its 200-day average ($0.86).
- 52-week range $0.46–$1.97; today's close sits at 1% of that range, 76.0% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — HUMA slides 4.4% to $0.48, a 52-week low
- Closed at $0.48, -4.40% vs the prior close of $0.50. Day range $0.47–$0.51, opened at $0.50.
- Volume was 4.28M shares, 0.7x its 50-day average of 6.26M.
- Price is -21.9% vs its 50-day average ($0.61) and -44.9% vs its 200-day average ($0.87).
- 52-week range $0.47–$2.55; today's close sits at 0% of that range, 81.3% below the 52-week high.
Oct 5, 2026 — HUMA slides 4.2% to $0.50, a 52-week low
- Closed at $0.50, -4.21% vs the prior close of $0.52. Day range $0.49–$0.52, opened at $0.52.
- Volume was 6.45M shares, 1.0x its 50-day average of 6.19M.
- Price is -18.8% vs its 50-day average ($0.62) and -42.5% vs its 200-day average ($0.87).
- 52-week range $0.49–$2.55; today's close sits at 1% of that range, 80.4% below the 52-week high.
Oct 2, 2026 — HUMA jumps 3.8% to $0.52
- Closed at $0.52, +3.78% vs the prior close of $0.50. Day range $0.50–$0.53, opened at $0.51.
- Volume was 5.40M shares, 0.9x its 50-day average of 6.18M.
- Price is -15.6% vs its 50-day average ($0.62) and -40.2% vs its 200-day average ($0.87).
- 52-week range $0.50–$2.55; today's close sits at 1% of that range, 79.5% below the 52-week high.
HUMA latest news & SEC filings
Every SEC filing by or about HUMA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 28, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 28, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Jones Keith Anthony bought 10,000 shares at $0.56 (≈$5.60K) on Sep 14, 2026
- Jones Keith Anthony bought 10,000 shares at $0.56 (≈$5.60K) on Sep 14, 2026
- Jones Keith Anthony bought 10,000 shares at $0.56 (≈$5.60K) on Sep 14, 2026
- Jones Keith Anthony bought 10,000 shares at $0.56 (≈$5.60K) on Sep 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 25, 2026 · Form 25-NSE — Notice that a security is being removed from exchange listing
Notice that a security is being removed from exchange listing
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Jones Keith Anthony bought 10,000 shares at $0.69 (≈$6.90K) on Aug 20, 2026
- Jones Keith Anthony bought 10,000 shares at $0.69 (≈$6.90K) on Aug 20, 2026
- Jones Keith Anthony bought 10,000 shares at $0.69 (≈$6.90K) on Aug 20, 2026
- Jones Keith Anthony bought 10,000 shares at $0.69 (≈$6.90K) on Aug 20, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 18, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $406.00K (prior year $301.00K) (+34.9% vs Jun 30, 2025)
- Net income: -$36.80M (prior year -$37.66M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.16 (prior year -$0.24) (loss narrowed vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jul 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 13, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 22, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade HUMA
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: Mar 19, 2026, Nov 12, 2025, Aug 11, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.28% (largest 24.3%). That is a volatile stock.
- Liquidity: about 6.40M shares (≈$2.75M) trade per day on average.
- 52-week position: $0.43 vs a range of $0.34–$1.89 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 17 open-market buys, 8 sales; latest: Keith Anthony Jones bought 10,000 shares on Sep 14, 2026.
- Latest filings: 8-K Sep 28, 2026; 10-Q Aug 12, 2026; 8-K Aug 12, 2026.
- Share count: 277.80M shares outstanding (Aug 10, 2026), +75.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
HUMA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.45 | 0.46 | 0.42 | 0.43 | 5.94M |
| Oct 15, 2026 | 0.37 | 0.45 | 0.35 | 0.44 | 20.79M |
| Oct 14, 2026 | 0.36 | 0.38 | 0.34 | 0.35 | 5.43M |
| Oct 13, 2026 | 0.39 | 0.39 | 0.36 | 0.36 | 12.35M |
| Oct 12, 2026 | 0.40 | 0.41 | 0.39 | 0.39 | 16.35M |
| Oct 9, 2026 | 0.44 | 0.45 | 0.39 | 0.41 | 8.60M |
| Oct 8, 2026 | 0.47 | 0.48 | 0.44 | 0.45 | 5.49M |
| Oct 7, 2026 | 0.48 | 0.48 | 0.46 | 0.47 | 3.91M |
| Oct 6, 2026 | 0.50 | 0.51 | 0.47 | 0.48 | 4.28M |
| Oct 5, 2026 | 0.52 | 0.52 | 0.49 | 0.50 | 6.45M |
| Oct 2, 2026 | 0.51 | 0.53 | 0.50 | 0.52 | 5.40M |
| Oct 1, 2026 | 0.52 | 0.53 | 0.50 | 0.50 | 3.00M |
| Sep 30, 2026 | 0.54 | 0.55 | 0.51 | 0.52 | 5.74M |
| Sep 29, 2026 | 0.55 | 0.55 | 0.53 | 0.53 | 3.61M |
| Sep 28, 2026 | 0.55 | 0.57 | 0.53 | 0.55 | 4.96M |
| Sep 25, 2026 | 0.56 | 0.57 | 0.55 | 0.56 | 2.62M |
| Sep 24, 2026 | 0.56 | 0.57 | 0.54 | 0.57 | 2.83M |
| Sep 23, 2026 | 0.59 | 0.59 | 0.56 | 0.57 | 3.43M |
| Sep 22, 2026 | 0.59 | 0.61 | 0.58 | 0.58 | 3.47M |
| Sep 21, 2026 | 0.60 | 0.61 | 0.57 | 0.59 | 3.41M |
About Humacyte
Humacyte (HUMA) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in DURHAM, NC. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1818382.
HUMA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John Philip Bamforth | Director | Jun 12, 2026 |
| Emery N. Brown | Director | Jun 12, 2026 |
| D Scott Coward | Director | Sep 28, 2026 |
| Michael T. Constantino | Director | Jun 12, 2026 |
| Brady W Dougan | Director | Jun 12, 2026 |
| Charles Bruce Green | Director | Jun 12, 2026 |
| Keith Anthony Jones | Director | Sep 15, 2026 |
| Paul Brian Kuznik | Director | Sep 28, 2026 |
| Laura E Niklason | President, CEO and Director | Jun 12, 2026 |
| Kathleen Sebelius | Director | Jun 12, 2026 |
| Diane Seimetz | Director | Jun 12, 2026 |
| Max N. Wallace | Director | Jun 12, 2026 |
| Susan Richards Windham-Bannister | Director | Jun 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Laura E Niklason | President, CEO and Director | Jun 12, 2026 |
| Shamik J Parikh | Chief Medical Officer | May 20, 2026 |
| Dale A. Sander | CFO and Chief Corp. Dev. Off | May 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 14, 2026 | Keith Anthony Jones | Buy | 10,000 | $0.56 |
| Sep 14, 2026 | Keith Anthony Jones | Buy | 10,000 | $0.56 |
| Sep 14, 2026 | Keith Anthony Jones | Buy | 10,000 | $0.56 |
| Sep 14, 2026 | Keith Anthony Jones | Buy | 10,000 | $0.56 |
| Aug 20, 2026 | Keith Anthony Jones | Buy | 10,000 | $0.69 |
| Aug 20, 2026 | Keith Anthony Jones | Buy | 10,000 | $0.69 |
| Aug 20, 2026 | Keith Anthony Jones | Buy | 10,000 | $0.69 |
| Aug 20, 2026 | Keith Anthony Jones | Buy | 10,000 | $0.69 |
| Aug 17, 2026 | Keith Anthony Jones | Buy | 30,000 | $0.59 |
| Aug 17, 2026 | Keith Anthony Jones | Buy | 30,000 | $0.59 |
| Aug 17, 2026 | Keith Anthony Jones | Buy | 30,000 | $0.59 |
| Aug 17, 2026 | Keith Anthony Jones | Buy | 30,000 | $0.59 |
| May 19, 2026 | Kathleen Sebelius | Buy | 56,818 | $0.88 |
| May 19, 2026 | Kathleen Sebelius | Buy | 56,818 | $0.88 |
| May 19, 2026 | Kathleen Sebelius | Buy | 56,818 | $0.88 |
HUMA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.04M | $-40.83M | -0.26 | $-105.04M |
| Dec 31, 2024 | $0 | $-148.70M | -1.26 | $-98.12M |
| Dec 31, 2023 | — | $-110.78M | -1.07 | $-73.31M |
| Dec 31, 2022 | — | $-11.96M | -0.12 | $-71.13M |
| Dec 31, 2021 | — | $-26.48M | -0.66 | $-81.19M |
Latest balance sheet: total assets $138.09M, total liabilities $106.83M, cash $79.90M (as of Jun 30, 2026).
HUMA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $0.67 |
| Mar 19, 2026 | 8-K Item 2.02 (results) | $0.85 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $1.25 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $1.75 |
| May 13, 2025 | 8-K Item 2.02 (results) | $1.73 |
| Mar 28, 2025 | 8-K Item 2.02 (results) | $1.96 |
| Nov 8, 2024 | 8-K Item 2.02 (results) | $5.78 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 10, 2024 | 8-K Item 2.02 (results) | — |
| Mar 22, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
| Aug 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on HUMA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.